Literature DB >> 12650672

Homology modelling of CYP2A6 based on the CYP2C5 crystallographic template: enzyme-substrate interactions and QSARs for binding affinity and inhibition.

D F V Lewis1, B G Lake, M Dickins, P S Goldfarb.   

Abstract

The results of homology modelling of the human P450 enzyme CYP2A6, based on the CYP2C5 crystallographic template structure are reported. A substantial number of selective substrates of the CYP2A6 enzyme fit the putative active site in a manner that is consistent with their known metabolites. Moreover, the evidence from site-directed mutagenesis experiments is in accordance with the current model, particularly in relation to complementary amino acid contacts within the haem environment. The binding of substrates is rationalized in terms of QSAR analyses and from a consideration of the contributory factors affecting the binding affinity. The latter approach appears to represent a highly correlated (R=0.99) method for estimating the relative strength of enzyme-substrate binding within CYP2A6-selective compounds, albeit within a fairly limited dataset of substrates.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12650672     DOI: 10.1016/s0887-2333(02)00132-7

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  7 in total

1.  Characterization of the novel CYP2A6*21 allele using in vivo nicotine kinetics.

Authors:  Nael Al Koudsi; Jill C Mwenifumbo; Edward M Sellers; Neal L Benowitz; Gary E Swan; Rachel F Tyndale
Journal:  Eur J Clin Pharmacol       Date:  2006-04-28       Impact factor: 2.953

Review 2.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

3.  Improved cytochrome P450 3A4 molecular models accurately predict the Phe215 requirement for raloxifene dehydrogenation selectivity.

Authors:  Chad D Moore; Kiumars Shahrokh; Stephen F Sontum; Thomas E Cheatham; Garold S Yost
Journal:  Biochemistry       Date:  2010-10-19       Impact factor: 3.162

4.  Development of a new predictive model for interactions with human cytochrome P450 2A6 using pharmacophore ensemble/support vector machine (PhE/SVM) approach.

Authors:  Max K Leong; Yen-Ming Chen; Hong-Bin Chen; Po-Hong Chen
Journal:  Pharm Res       Date:  2008-12-23       Impact factor: 4.200

5.  Single mutations change CYP2F3 from a dehydrogenase of 3-methylindole to an oxygenase.

Authors:  Jaya S Kartha; Konstantine W Skordos; Hao Sun; Clifton Hall; LaHoma M Easterwood; Christopher A Reilly; Eric F Johnson; Garold S Yost
Journal:  Biochemistry       Date:  2008-08-22       Impact factor: 3.162

6.  Inhibitory potency of 8-methoxypsoralen on cytochrome P450 2A6 (CYP2A6) allelic variants CYP2A6 15, CYP2A6 16, CYP2A6 21 and CYP2A6 22: differential susceptibility due to different sequence locations of the mutations.

Authors:  Kai Hung Tiong; Nafees Ahemad Mohammed Yunus; Beow Chin Yiap; Eng Lai Tan; Rusli Ismail; Chin Eng Ong
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

Review 7.  Utility of homology models in the drug discovery process.

Authors:  Alexander Hillisch; Luis Felipe Pineda; Rolf Hilgenfeld
Journal:  Drug Discov Today       Date:  2004-08-01       Impact factor: 7.851

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.